pyridostigmine bromide (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the pyridostigmine bromide drug offered from Cadila Healthcare Limited. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | pyridostigmine bromide |
SUBSTANCE NAME: | PYRIDOSTIGMINE BROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-08-07 |
END MARKETING DATE: | 0000-00-00 |
pyridostigmine bromide HUMAN PRESCRIPTION DRUG Details:
Item Description | pyridostigmine bromide from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 60(mg/1) |
START MARKETING DATE: | 2015-08-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65841-819_ced4beb2-1305-4bf8-a8b6-0bf060b9f22c |
PRODUCT NDC: | 65841-819 |
APPLICATION NUMBER: | ANDA205650 |
Other PYRIDOSTIGMINE BROMIDE Pharmaceutical Manufacturers / Labelers: